{
"NDC": {
"NDCCode": "70748-211-06",
"PackageDescription": "1 BOTTLE in 1 CARTON (70748-211-06) / 30 TABLET in 1 BOTTLE",
"NDC11Code": "70748-0211-06",
"ProductNDC": "70748-211",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Dasatinib",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Dasatinib",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20260130",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA214350",
"LabelerName": "Lupin Pharmaceuticals, Inc.",
"SubstanceName": "DASATINIB",
"StrengthNumber": "80",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-03-03",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260130",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}